MTOR mutation
|
RCC
|
MTOR mutation
|
RCC
|
sunitinib Sensitive: B - Late Trials
|
sunitinib Sensitive: B - Late Trials
|
MTOR mutation
|
RCC
|
MTOR mutation
|
RCC
|
everolimus Sensitive: C2 – Inclusion Criteria
|
everolimus Sensitive: C2 – Inclusion Criteria
|
MTOR mutation
|
RCC
|
MTOR mutation
|
RCC
|
temsirolimus Sensitive: C3 – Early Trials
|
temsirolimus Sensitive: C3 – Early Trials
|
MTOR mutation
|
RCC
|
MTOR mutation
|
RCC
|
mTOR inhibitor Sensitive: C3 – Early Trials
|
mTOR inhibitor Sensitive: C3 – Early Trials
|
MTOR mutation
|
Germ Cell Tumors
|
MTOR mutation
|
Germ Cell Tumors
|
everolimus Sensitive: C3 – Early Trials
|
everolimus Sensitive: C3 – Early Trials
|